BioStem Technologies, Inc. (BSEM) shareholders
Close on Nov 20, 2026Market cap $11.34MP/E –Yield –
Ownership
Who owns BioStem Technologies's shares
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Andrew Van Vurst | 3,854,452 | 18.40% | 13G (passive) | Sep 30, 2026 |
| Jason Matuszewski | 3,665,899 | 17.40% | 13G (passive) | Sep 30, 2026 |
| The PNC Financial Services Group, Inc. | 1,941,390 | 10.40% | 13G (passive) | Oct 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Jason Matuszewski | Chief Executive Officer, Director, 10% owner | 1,539,251 | 8.62% | Nov 19, 2026 |
| Vurst Andrew Smith-Van | Chief Operating Officer, Director, 10% owner | 1,789,809 | 10.03% | Oct 9, 2026 |
| Brandon Poe | Chief Financial Officer | 60,763 | 0.34% | Nov 13, 2026 |
| Michael A. Fortunato | Chief Accounting Officer | 69,634 | 0.39% | Nov 10, 2026 |
| Barry Hassett | Chief Commercial Officer | 5,256 | 0.03% | Nov 3, 2026 |
| Katherine Gorrell | CLCO | – | – | Aug 14, 2026 |
| Kenneth Howard Warrington Jr | Director | 33,928 | 0.19% | Sep 17, 2026 |
| Mark A. Glickman | Director | 7,671 | 0.04% | Aug 28, 2026 |
| Hannaway Rayna Lesser | Director | 7,671 | 0.04% | Aug 28, 2026 |
| Jodi Ungrodt | Director | 11,295 | 0.06% | Aug 28, 2026 |
| Steven D. Sonenreich | Director | 7,671 | 0.04% | Aug 28, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Jason Matuszewski Chief Executive Officer, Director, 10% owner | Nov 17, 2026 | Sale | −14,300 | $1.00 | $14.30K | 1,539,251 |
| Brandon Poe Chief Financial Officer | Nov 11, 2026 | Option exercise | +2,699 | – | – | 60,763 |
| Michael A. Fortunato Chief Accounting Officer | Nov 9, 2026 | Option exercise | +970 | – | – | 69,634 |
| Barry Hassett Chief Commercial Officer | Nov 1, 2026 | Option exercise | +253 | – | – | 5,256 |
| Vurst Andrew Smith-Van Chief Operating Officer, Director, 10% owner | Oct 7, 2026 | Option exercise | +250,000 | $2.00 | $500.00K | 1,789,809 |
| Jason Matuszewski Chief Executive Officer, Director, 10% owner | Oct 7, 2026 | Option exercise | +250,000 | $2.00 | $500.00K | 1,553,551 |
| Vurst Andrew Smith-Van Chief Operating Officer, Director, 10% owner | Sep 17, 2026 | Option exercise | +9,574 | – | – | 1,539,809 |
| Jason Matuszewski Chief Executive Officer, Director, 10% owner | Sep 17, 2026 | Option exercise | +16,650 | – | – | 1,303,552 |
| Kenneth Howard Warrington Jr Director | Sep 15, 2026 | Option exercise | +1,694 | – | – | 33,928 |
| Brandon Poe Chief Financial Officer | Sep 15, 2026 | Option exercise | +1,694 | – | – | 58,062 |
| Vurst Andrew Smith-Van Chief Operating Officer, Director, 10% owner | Sep 15, 2026 | Option exercise | +7,622 | – | – | 1,530,235 |
| Michael A. Fortunato Chief Accounting Officer | Sep 15, 2026 | Option exercise | +4,234 | – | – | 68,664 |
| Jason Matuszewski Chief Executive Officer, Director, 10% owner | Sep 15, 2026 | Option exercise | +8,469 | – | – | 1,286,902 |
| Barry Hassett Chief Commercial Officer | Sep 9, 2026 | Option exercise | +500 | – | – | 5,003 |
| Mark A. Glickman Director | Aug 27, 2026 | Option exercise | +7,671 | – | – | 7,671 |
| Hannaway Rayna Lesser Director | Aug 27, 2026 | Option exercise | +7,671 | – | – | 7,671 |
| Jodi Ungrodt Director | Aug 27, 2026 | Option exercise | +5,647 | – | – | 11,295 |
| Steven D. Sonenreich Director | Aug 27, 2026 | Option exercise | +7,671 | – | – | 7,671 |
| Kenneth Howard Warrington Jr Director | Aug 27, 2026 | Option exercise | +5,094 | – | – | 32,234 |
| Brandon Poe Chief Financial Officer | Aug 11, 2026 | Option exercise | +10,634 | – | – | 56,368 |
| Michael A. Fortunato Chief Accounting Officer | Aug 9, 2026 | Option exercise | +970 | – | – | 64,430 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of BioStem Technologies's stock actually held short. Settlement fails (shares not delivered on time) peaked at 11,995 shares on Oct 14, 2026 over the last 90 days.
See a number that looks wrong?